In the last 10 years alone, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming increasingly rare, making way for cross-company manufacturing collaborations and partnerships to better meet the changing demands of the life sciences market.
In collaboration with other leading bioscientists, Emerson's Michelle Adkins contributed to a BioPhorum paper outlining a vision for digital maturity in integration between biomanufacturers and partner organizations. The paper explores the benefits of improved digital integration to enhance the patient experience while improving business outcomes.
Digital integration leads to standardization
At the heart of this transition to improved digital integration is the standardization of integration approaches. Currently, many organizations are working with highly complex digital integration architectures. As the paper details, the experts suggest that an industry-standard approach to data and information sharing is key to improving operations and maintaining scalability as the trend towards collaborations and partnerships continues to shape the life sciences landscape.
